AbstractObjectiveTo quantify the comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with use of adenovirus […]
Category: COVID-19
In July 2021 the US Food and Drug Administration (FDA) quietly disclosed findings of a potential increase in […]
Will we continue to need annual covid boosters?Eleanor Riley, professor of immunology at the University of Edinburgh, says, […]
It must be a fraught task, writing about long covid. The list of symptoms is huge and we […]
Greenhalgh and colleagues’ Practice Pointer1 and the Opinion article from Long Covid SOS2 serve as a reminder that […]
AbstractObjectivesTo describe symptoms and symptom clusters of post-covid syndrome six to 12 months after acute infection, describe risk […]
AbstractObjectiveTo compare the effectiveness of a primary covid-19 vaccine series plus booster doses with a primary series alone […]
The number of people admitted to hospital with covid-19 in England rose by almost a third last week, […]
Key messagesThe paucity of evidence during the early phase of the pandemic provided an opportunity for real time […]
Most countries haven’t learnt all the lessons of the covid pandemic and need to take further measures to […]